Aubeux Davy, Peters Ove A, Hosseinpour Sepanta, Tessier Solène, Geoffroy Valérie, Pérez Fabienne, Gaudin Alexis
Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, 44042, Nantes, France.
Université de Nantes, UFR Odontologie, 44042, Nantes, France.
BMC Oral Health. 2021 May 24;21(1):276. doi: 10.1186/s12903-021-01619-8.
Endodontics is the branch of dentistry concerned with the morphology, physiology, and pathology of the human dental pulp and periradicular tissues. Human dental pulp is a highly dynamic tissue equipped with a network of resident immunocompetent cells that play major roles in the defense against pathogens and during tissue injury. However, the efficiency of these mechanisms during dental pulp inflammation (pulpitis) varies due to anatomical and physiological restrictions. Uncontrolled, excessive, or unresolved inflammation can lead to pulp tissue necrosis and subsequent bone infections called apical periodontitis. In most cases, pulpitis treatment consists of total pulp removal. Although this strategy has a good success rate, this treatment has some drawbacks (lack of defense mechanisms, loss of healing capacities, incomplete formation of the root in young patients). In a sizeable number of clinical situations, the decision to perform pulp extirpation and endodontic treatment is justifiable by the lack of therapeutic tools that could otherwise limit the immune/inflammatory process. In the past few decades, many studies have demonstrated that the resolution of acute inflammation is necessary to avoid the development of chronic inflammation and to promote repair or regeneration. This active process is orchestrated by Specialized Pro-resolving lipid Mediators (SPMs), including lipoxins, resolvins, protectins and maresins. Interestingly, SPMs do not have direct anti-inflammatory effects by inhibiting or directly blocking this process but can actively reduce neutrophil infiltration into inflamed tissues, enhance efferocytosis and bacterial phagocytosis by monocytes and macrophages and simultaneously inhibit inflammatory cytokine production. Experimental clinical application of SPMs has shown promising result in a wide range of inflammatory diseases, such as renal fibrosis, cerebral ischemia, marginal periodontitis, and cancer; the potential of SPMs in endodontic therapy has recently been explored. In this review, our objective was to analyze the involvement and potential use of SPMs in endodontic therapies with an emphasis on SPM delivery systems to effectively administer SPMs into the dental pulp space.
牙髓病学是牙科学的一个分支,涉及人类牙髓和根尖周组织的形态学、生理学和病理学。人类牙髓是一种高度动态的组织,配备有常驻免疫活性细胞网络,这些细胞在抵御病原体和组织损伤过程中发挥主要作用。然而,由于解剖学和生理学限制,这些机制在牙髓炎症(牙髓炎)期间的效率各不相同。不受控制、过度或未解决的炎症可导致牙髓组织坏死以及随后称为根尖周炎的骨感染。在大多数情况下,牙髓炎治疗包括彻底清除牙髓。虽然这种策略成功率很高,但这种治疗也有一些缺点(缺乏防御机制、愈合能力丧失、年轻患者牙根形成不完全)。在相当多的临床情况下,由于缺乏其他可限制免疫/炎症过程的治疗工具,进行牙髓摘除和牙髓病治疗的决定是合理的。在过去几十年中,许多研究表明,急性炎症的消退对于避免慢性炎症的发展以及促进修复或再生是必要的。这个活跃过程由专门的促消退脂质介质(SPM)协调,包括脂氧素、消退素、保护素和maresin。有趣的是,SPM没有通过抑制或直接阻断这个过程而产生的直接抗炎作用,但可以积极减少中性粒细胞向炎症组织的浸润,增强单核细胞和巨噬细胞的胞葬作用和细菌吞噬作用,同时抑制炎性细胞因子的产生。SPM的实验性临床应用在广泛的炎症性疾病中显示出有希望的结果,如肾纤维化、脑缺血、边缘性牙周炎和癌症;最近已经探索了SPM在牙髓病治疗中的潜力。在这篇综述中,我们的目的是分析SPM在牙髓病治疗中的参与情况和潜在用途,重点是SPM递送系统,以便有效地将SPM施用于牙髓腔。